Peptone featured in Nature Biotechnology and Drug Discovery

Peptone Ltd. is featured in Nature Biotechnology and Drug Discovery

We have sat together with an editorial team of Nature and put together a short commercial executive summary of Peptone for future employees, collaborators and stakeholders. The article is readily available from the following link. A downloadable PDF version can be obtained here. We would appreciate if all the commercial-related matters and partnering questions were sent to our partnering email.

About Nature

A weekly, international journal, publishing papers from any area of science with great potential impact and whose importance extends well beyond the confines of the specific discipline concerned. Nature has the highest impact factor of any journal publishing basic scientific research. Nature also publishes Reviews, as well as a broad range of informal material in the form of Editorials, News and News Features, Correspondence, Opinion, News and Views, Books and Arts, Futures (the award-winning science-fiction series) and NatureJobs (articles on careers and recruitment). The journal also publishes regular supplements, including Insights, Outlooks and Technology Features. Nature publishes much online-only information, including the award-winning daily Nature News, blogs, regular web focuses (collections of topical material, often from the journal’s archive) and other web-only special features. Nature has editorial offices in London, New York, Washington DC, San Francisco, Tokyo, Berlin, Munich and Paris. Submit to Nature or email the journal editorial office. For more information about the journal visit Nature.com.

Peptone Media

Clare Homer
clare@transatlanticent.com
+44 (0)7825 744134

Victoria Holden
victoria@transatlanticent.com
+44 (0)7803 328465